Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure

Association of 5-Hydroxytryptamine 3 Receptor Antagonists With the Prognosis of Liver Failure

Liver failure is a severe clinical syndrome with high mortality. 5-Hydroxytryptamine 3 receptor antagonists (5-HT3RAs) can reduce liver damage in animal models. We investigated whether 5-HT3RAs may improve the prognosis of liver failure. We analyzed the 28 and 90 days mortality of liver failure pati...

Full description

Bibliographic Details
Main Authors: Yuting Chen, Jingkang Sun, Xiude Fan, Xiaoyun Wang, Lu Zeng, Xiaoge Zhang, Kun Zhang, Na Li, Qunying Han, Zhengwen Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
liver failure
5-hydroxytryptamine 3 receptor antagonist
prognosis
short-term survival
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.648736/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.648736/full

Similar Items